Brain Tumor Clinical Trials
Brain tumor clinical trials are designed to identify treatments that are potentially more effective and/or have fewer side effects than standard brain tumor treatments. Clinical trials are recommended for patients with tumors where results of treatment are generally poor, or that are considered incurable with conventional treatment. Clinical trials also are recommended for most pediatric patients with brain tumors.
Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center patients have access to numerous brain tumor clinical trials, some designed by Cleveland Clinic physicians, others as a part of multi-center trials in partnership with pharmaceutical companies or research consortia. The Burkhardt Brain Tumor Center actively participates in several of these clinical trial groups, including:
- American Brain Tumor Consortium(ABTC)
- Southwest Oncology Group (SWOG)
- Radiation Therapy Oncology Group (RTOG)
- American College of Surgeons Oncology Group (AcoSOG)
- Children's Oncology Group (COG)
These associations contribute to the exciting environment of clinical trial research and development, discussion and the sharing of data that is so important to the dynamic evolution of the therapeutic protocols of tomorrow's brain tumor treatments.
To schedule an evaluation with a Burkhardt Brain Tumor Center specialist, please contact us at 216.636.5860, or toll-free at 866.588.2264.
Current Open Protocols & IRB Studies For Treating Brain Tumors
Anaplastic astrocytoma»
Newly Diagnosed
Recurrent
Anaplastic oligodendroglioma »
Newly Diagnosed
Recurrent
Anaplastic oligodendroglioma, mixed»
Newly Diagnosed
Recurrent
Oligoastrocytoma, mixed»
Newly Diagnosed
Recurrent
Glioblastoma Multiforme (GBM)»
Newly Diagnosed
Recurrent
Gliosarcoma»
Newly Diagnosed
Recurrent
Metastases»
Lymphoma, PCNS»
Last updated on 4/16/12
The Cancer Answer Line: 866.CCF.8100 (866.223.8100)
